Bewertung der Sicherheit von COVID-19-Impfstoffen durch das Paul-Ehrlich-Institut

This procedure is a written parliamentary question aimed at clarifying how the Paul Ehrlich Institute evaluates the safety and efficacy of COVID-19 vaccines. It seeks to ensure transparency regarding the monitoring of side effects and the regulatory processes used to protect public health. The findings affect the general public and healthcare providers by providing clarity on the safety standards and oversight mechanisms applied to vaccines used in Germany.